Showing results (181-190 of 465) with videos related to

Sort By:
Pageof 47
JACC. Cardiovascular Imaging|March 8, 2023
Diagnostic and Prognostic Role of Cardiac Magnetic Resonance in MINOCA: Systematic Review and Meta-AnalysisNiya Mileva, Pasquale Paolisso, Emanuele Gallinoro, et al.
Biomedicines|July 27, 2024
Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge ResearchRaffaella Mistrulli, Armando Ferrera, Luigi Salerno, et al.
International Journal of Cardiology|July 9, 2016
Relationship of asymmetric dimethylarginine (ADMA) with extent and functional severity of coronary atherosclerosisFabio Mangiacapra, Micaela Conte, Chiara Demartini, et al.
Journal of Cardiovascular Translational Research|December 7, 2017
T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease PatientsTeresa Strisciuglio, Emanuele Barbato, Chiara De Biase, et al.
The Canadian Journal of Cardiology|December 13, 2025
Evolving Indications for Transcatheter Aortic Valve Implantation: Key Issues From Procedural Challenges to Lifetime ManagementPasquale Paolisso, Davide Ausiello, Francesco Cefalì, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 10, 2020
The impact of the extent of side branch disease on outcomes following bifurcation stentingMarco Zimarino, Emanuele Barbato, Sunao Nakamura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2014
α2A-Adrenergic receptor polymorphism potentiates platelet reactivity in patients with stable coronary artery disease carrying the cytochrome P450 2C19*2 genetic variantAaron J Peace, Fabio Mangiacapra, Els Bailleul, et al.
Journal of Thrombosis and Thrombolysis|February 4, 2011
Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrelMichalis Hamilos, Olivier Muller, Argyrios Ntalianis, et al.
Atherosclerosis|November 11, 2006
GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic diseaseEmanuele Barbato, Alexandre Berger, Leen Delrue, et al.
Pageof 47